Lingerfelt strategically invests in and develops medical and life science facilities that support the evolving needs of healthcare providers, research institutions, and biotechnology firms. With decades of experience across healthcare real estate and complex asset classes, we deliver purpose-built environments that meet stringent regulatory requirements while enhancing operational performance. From outpatient centers and specialty clinics to lab-enabled spaces and biomedical campuses, our portfolio is designed to serve growing demand in both core and emerging healthcare markets. Our approach blends market intelligence, technical execution, and a deep understanding of end-user needs—resulting in high-quality, future-ready facilities that create long-term value for tenants, partners, and investors.
Lingerfelt targets medical office real estate development and life science properties that support long-term growth in healthcare delivery, research, and innovation. Our focus includes development and commercial real estate acquisition opportunities that serve specialized users and offer strong fundamentals, sustainable demand, and value-add potential.
Location & Site Characteristics:
Transaction Characteristics:
Target Sub-Types:
| Outpatient Care Centers | Specialty Clinics and Diagnostic Facilities |
| Ambulatory Surgery Centers (ASCs) | Medical Office Buildings (MOBs) |
| Life Science Labs & R&D Facilities | Biomedical and Biotech Campuses |
| Health System–Affiliated or Anchored Properties | Behavioral Health and Wellness Facilities |
Lingerfelt actively pursues strategic acquisitions of medical and life science facilities in high-growth markets, targeting stabilized and value-add assets that serve health systems, specialty providers, and research institutions.
We selectively develop Class A medical and life science facilities on a speculative basis in markets with strong healthcare demand drivers, limited supply, and proximity to major medical campuses or research clusters.
Lingerfelt partners with healthcare providers, life science users, and research organizations to deliver custom-built facilities tailored to their clinical, lab, or administrative needs—ensuring precision, compliance, and long-term operational efficiency.
Lingerfelt identified the West Creek MOB opportunity through an off-market transaction in December 2013, securing a well-located site in a supply-constrained healthcare corridor. The investment strategy centered on a pre-leased development approach designed to mitigate lease-up risk while capturing development yield spread. With 67% of the space pre-leased to a long-term, creditworthy master tenant, the plan leveraged moderate construction financing to deliver a Class-A, investment-grade medical office building with long-term upside potential.
Construction began in late 2013, with the core and shell delivered in 2014. During the hold period, the master lease was strategically burned down as Lingerfelt executed long-term leases with a strong mix of regional medical providers, driving occupancy from 67% to nearly 96%. In 2017, the asset was expanded with a 9,000 SF surgery center, prompting an equity recapitalization that returned capital early and enhanced JV returns. The project remained under expert oversight throughout construction, lease-up, and repositioning, ensuring high operational performance and tenant retention.
Following a successful lease-up and a 9,000 SF expansion to include a surgery center, West Creek MOB was sold in 2019 to Montecito Medical Real Estate. The transaction reflected strong market demand for stabilized medical office assets and demonstrated the value of Lingerfelt’s integrated development and asset management approach.
